Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

National Institutes of Health

MODERATE Tx General

Strategy Notes

—

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: —
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-22 OPEN → INELIGIBLE · The SBIR Phase IIB Bridge Award requires the applicant to be a small business concern (SBC) in the United States, and the applicant is an independent researcher in Nigeria with no US-based small business affiliation.